Tarsus Pharmaceuticals
TARS
TARS
43 hedge funds and large institutions have $294M invested in Tarsus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
17
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$3.93M |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
$5.46M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$10.3M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
$14.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
$202K |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
$31.6M |
| 2 |
JGC
J. Goldman & Co
New York
|
$0 |
| 3 |
Morgan Stanley
New York
|
$253K |
| 4 |
VEA
Virtus ETF Advisers
New York
|
$0 |
| 5 |
Invesco
Atlanta,
Georgia
|
$538K |
